Latest Posts

Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy. The $10.8 million project, “Personalized medicine in the treatment of epilepsy”, forms the Canadian Epilepsy Network (CENet) and is led by Dr.…

Génome Québec pays tribute to Fred Sanger, who died on Tuesday 19 November 2013, at the age of 95. He was the quiet giant of genomics, the father of an area of science that we will explore for decades to come. His achievements rank alongside those of Francis Crick, James Watson, Rosalind Franklin and Maurice…

A team of clinical researchers led by CHU de Québec and Université Laval has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive…

Pr. Mohamed Hijri’s excellent presentation at the TEDxUdeM conference held in Montréal on March 11, 2012 caught the attention of the persons responsible for TED conferences in the US. As of today, his presentation on a microscopic mushroom is online in its French original version on TED.com (English subtitles).

Montréal, October 21, 2013 – Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. “We are honoured to have…

Montréal, October 16, 2013 – Génome Québec welcomes the National Research and Innovation Policy (PNRI) announced by the Québec Government. The policy is a major step forward in the government’s vision and support of research and innovation, since it now places the sector at the centre of its economic strategy. The approach reflects the changes…

Researchers Worldwide Take Part in one of History’s Largest Scientific Consortia Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a…

Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to…

In a genetic study of childhood epilepsies, an international team of researchers including Dr. Patrick Cossette at the CHUM Research Centre (CRCHUM), has linked two new genes to severe forms of disease and provides a novel strategy for identifying therapy targets. Published in Nature, this study used a cutting-edge genetic technique called exome sequencing to…

A team of researchers led by CHU de Québec and Université Laval, has received CAN$10.5 million from Genome Canada, the Canadian Institutes of Health Research (CIHR), Génome Québec and other partners to conduct a large-scale comparative effectiveness study on non-invasive prenatal screening techniques. Dr. François Rousseau, professor at the Faculty of Medicine of Université Laval…